This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Golden Biotechnology Corporation. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Wan-Ling Tsou in Tumor Inhibition
Introduction
Wan-Ling Tsou is a notable inventor based in Taipei Hsien, Taiwan, known for his groundbreaking work in developing novel pharmaceutical compounds. With a focus on cancer treatment, his innovations aim to provide advanced solutions for tumor growth inhibition. His dedication to research and innovation has resulted in significant contributions to the field of biotechnology.
Latest Patents
Wan-Ling Tsou holds a patent for a compound extracted and purified from Antrodia camphorate. The invention describes 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone, which has not been previously discovered in this specific fungus. This compound is particularly effective in inhibiting the growth of various cancer cells, including those associated with breast cancer, hepatic cancer, and prostate cancer. Furthermore, it shows potential for use as a pharmaceutical composition to combat tumor growth and may also offer health benefits in preventing heart and blood vessel diseases due to its antioxidant properties.
Career Highlights
Wan-Ling is currently affiliated with Golden Biotechnology Corporation, where he leverages his expertise to advance the company's research in biotechnology. His work is characterized by a commitment to innovative drug development that addresses critical health challenges posed by cancer and cardiovascular diseases.
Collaborations
Throughout his career, Wan-Ling has collaborated with talented professionals, including Sheng-Yun Liu and Wu-Che Wen. Together, they contribute to a collaborative research environment aimed at driving significant advancements in the biotechnology sector.
Conclusion
Wan-Ling Tsou's contributions to the field of biotechnology and his innovative patent represent a critical step forward in cancer treatment and health improvement. His commitment to research and collaboration exemplifies the importance of innovation in addressing complex health challenges. As he continues to work within Golden Biotechnology Corporation, his efforts may lead to transformative advancements in medical science.